Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. (CURLF) is a prominent international provider of consumer cannabis products, known for its mission to enhance lives by sharing and celebrating the power of the plant. It operates under various brands like Curaleaf, Select, Grassroots, JAMS, Find, and Zero Proof in the medical and adult-use markets. With operations in over 15 countries globally, Curaleaf focuses on quality, expertise, and accessibility in the cannabis industry.
Recently, Curaleaf announced a strategic acquisition of Northern Green Canada, a licensed Canadian cannabis producer with a focus on international market expansion. This move aligns with Curaleaf's vision of becoming a global cannabis company with a strong presence in North America, Europe, and Australasia. The acquisition of NGC provides Curaleaf with EU-GMP certification, enabling the company to strengthen its supply chain, improve margins, and extend its global footprint.
Under the leadership of Boris Jordan, Executive Chairman, and Matt Darin, CEO, Curaleaf continues to drive growth and innovation within the cannabis space. The company's commitment to delivering high-quality products and patient access remains a top priority in evolving markets and regulatory environments.
Curaleaf Holdings reported record financial results for Q4 and FY2020. Managed revenue reached $233.3 million in Q4, reflecting a 186% year-over-year increase, while total revenue was $230.3 million, up 205% from the prior year. For FY2020, managed revenue was $653.0 million, a 161% growth, with total revenue at $626.6 million, up 184%. Adjusted EBITDA for Q4 reached $53.8 million, a 289% increase. Despite these gains, the company reported a net loss of $35.3 million for Q4.
Curaleaf aims to expand further with its entry into the European market.
Curaleaf announced a definitive agreement to acquire EMMAC Life Sciences for approximately US$286 million, consisting of 85% Curaleaf shares and 15% cash. This acquisition provides Curaleaf with a strategic entry into the European cannabis market, leveraging EMMAC's established operations across key countries like the UK, Germany, and Portugal. The deal includes contingent consideration of up to US$57 million based on performance milestones. Curaleaf aims to expand its brand presence in Europe, anticipating the market could exceed US$120 billion in the future.
Curaleaf Holdings has announced the expansion of its Select brand products into Utah, making it available across 17 states. Starting with the Select Elite cartridges, these products aim to enhance patient access to high-quality medical cannabis. The initial rollout is set to begin at the Curaleaf pharmacy in Lehi, UT. Select continues to meet high-quality standards and aims to educate consumers. The company's extensive operational footprint includes 101 dispensaries and serves over 18,400 active patient cardholders in Utah.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has announced that it will report its financial results for Q4 and the fiscal year ending December 31, 2020, on March 9, 2021. The company will host a conference call at 4:30 p.m. ET for a discussion on operational and financial highlights. Curaleaf operates in 23 states with 101 dispensaries and a workforce of over 3,800 employees. The results are anticipated to provide investors with insights into the company’s performance in the growing cannabis market.
Curaleaf has opened its second dispensary in St. Petersburg, Florida, marking its 34th location in the state and 98th nationwide. This expansion aims to meet the growing demand for medical cannabis, with Florida's sales reaching $1.2 billion in 2020. The new dispensary offers a variety of premium products, including Select, America's top oil brand. Curaleaf is committed to providing quality patient care and education, encouraging both new and returning patients to visit their locations.
Curaleaf Holdings, Inc. (CURLF) has launched its new Live Blends vape cartridges in Florida, which feature a unique formulation of live and botanical terpenes. This innovative product aims to enhance the flavor and effects for medical cannabis patients. Each cartridge combines strain-specific Solventless Terpene Extract with a micro-infusion of botanical terpenes, providing a clean and broad spectrum of cannabis compounds. As the first market for Live Blends, Florida serves a growing medical patient base, with over 420,000 registered patients and around 5,000 new patients weekly.
Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), a top cannabis operator in the U.S., announced that Executive Chairman Boris Jordan will present the keynote at the Benzinga Virtual Cannabis Capital Conference on October 15, 2020. The session will be moderated by Benzinga CEO Jason Raznick. Curaleaf's management will also hold virtual investor meetings on the same day, which can be accessed through their investor relations website. Curaleaf operates in 23 states, with 95 dispensaries and over 30 processing sites, employing more than 3,000 individuals.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) is expanding its footprint in Florida by opening two new dispensaries in the Florida Panhandle: Curaleaf Pensacola on October 15 and Curaleaf Panama City on October 16. These locations aim to enhance access to medical cannabis for patients in the area, contributing to Curaleaf's goal of serving over 420,000 registered patients in Florida. Furthermore, the company is set to begin harvesting from its new cultivation center, with innovative products launching in November.
FAQ
What is the current stock price of Curaleaf Hldgs (CURLF)?
What is the market cap of Curaleaf Hldgs (CURLF)?
What is Curaleaf Holdings, Inc. known for?
Who are the key leaders at Curaleaf?
What recent acquisition has Curaleaf made?
Where does Curaleaf operate?
